Related Experiment Videos
T-cell reactivity in myasthenia gravis
J Newsom-Davis1, G Harcourt, N Sommer
1Department of Clinical Neurology, University of Oxford, UK.
Journal of Autoimmunity
|June 1, 1989
Summary
Myasthenia gravis (MG) patients show significant T-cell reactivity to human acetylcholine receptor (AChR) sequences, unlike controls. This highlights the importance of using human AChR components to accurately assess T-cell responses in MG.
Area of Science:
- Immunology
- Neuroimmunology
- Autoimmune Diseases
Background:
- Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
- T-cell responses to acetylcholine receptor (AChR) are implicated in MG pathogenesis.
- Previous studies used non-human AChR, limiting relevance to human immune responses.
Purpose of the Study:
- To investigate T-cell reactivity in MG patients using human AChR sequences.
- To identify specific human AChR epitopes that elicit T-cell responses in MG.
- To establish T-cell lines and clones for further functional studies in MG.
Main Methods:
- Peripheral blood lymphocytes (PBL) from MG patients and controls were stimulated with Torpedo AChR (T-AChR), recombinant human AChR alpha-subunit (r37-437), and synthetic peptides.
- T-cell proliferation assays were performed.
- T-cell lines and clones were generated and characterized for reactivity.
Main Results:
- A higher proportion of MG patients' PBL responded to r37-437 compared to controls.
- MG patients showed specific responses to certain synthetic peptides of the human alpha-subunit.
- T-cell lines and clones derived from MG patients demonstrated significant reactivity to human AChR components.
Conclusions:
- Human AChR sequences are crucial for accurately assessing T-cell responses in myasthenia gravis.
- Specific T-cell epitopes within the human AChR alpha-subunit are identified.
- The generated T-cell lines and clones provide a valuable tool for dissecting the role of T-cells in MG pathogenesis and anti-AChR antibody production.